Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Original Research Article


 

Long-Term Effect of HAART on Biochemical Profiles of HIV/AIDS Patients in a Tertiary Health Facility in Benin City, Nigeria

 

Shakirat I Bello1,3, Abel N Onunu2, and Patrick O Erah4*

1Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, 2Department of Internal Medicine, University of Benin Teaching Hospital, 3Department of Clinical Pharmacy & Pharmacy Practice, and 4Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria

 

*For correspondence: Email: patrick.erah@uniben.edu; Tel: +234-805-526-3622

 

Received: 8 July 2014                                                                            Revised accepted: 11 October 2014

 

Tropical Journal of Pharmaceutical Research, November 2014; 13(11): 1941-1946

http://dx.doi.org/10.4314/tjpr.v13i11.24   

Abstract

 

Purpose: To assess the long-term effect of highly active antiretroviral therapy (HAART) on biochemical parameters of HIV-infected patients in University of Benin Teaching Hospital (UBTH), Benin City, Nigeria.

Methods: HIV/AIDS patients on HAART for 2 - 8 years (297), those who were not on HAART (112, positive control), and healthy subjects (103, negative control) were recruited in the Infectious Diseases Clinic (IDC) of UBTH. Their sera were assayed for biochemical parameters. WHOQoL bref instrument was used to assess patients’ Quality of life (QoL).

Results: Patients who have been on HAART had significantly elevated ALT and AST levels (p < 0.001) but mild liver toxicity. QoL of these patients was not significantly different from that of the healthy controls. The levels of Na+ (133.4 ± 5.2 mmol/l), K+ (3.6 ± 0.4 mmol/l) and Cl- (101.3 ± 4.0 mmol/l) were significantly lower in patients on HAART than those of the positive (137.5 ± 5.1, 3.9 ± 0.5, 104.3 ± 5.7 mmol/l respectively, p < 0.001). Also, levels of creatinine (0.8 ± 0.2 mg/dl), TBil (0.5 ± 0.2 mg/dl), and CB (0.3 ± 0.5 mg/dl) were significantly higher in patients on HAART than those of either the positive (0.7 ± 0.3, 0.4 ± 0.2, 0.2 ± 0.1 mg/dl) or negative (0.7 ± 0.3, 0.3 ± 0.1, 0.2 ± 0.1 mg/dl) controls respectively (p < 0.001).

Conclusion: Treatment with HAART for 2 - 8 years may not produce severe hepatotoxicity in HIV/AIDS patient though mild liver toxicity should be expected. The patients’ QoL was not negatively affected by the use of HAART for 2 - 8 years.

 

Keywords: Biochemical parameters, HIV/AIDS, Long-term HAART, Quality of life (QoL).

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net